Whitehawk Therapeutics (WHWK) Competitors $1.85 -0.10 (-5.13%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock WHWK vs. ATXS, AURA, ARCT, GLUE, RNAC, CADL, INBX, PRTA, ALT, and TNXPShould you be buying Whitehawk Therapeutics stock or one of its competitors? The main competitors of Whitehawk Therapeutics include Astria Therapeutics (ATXS), Aura Biosciences (AURA), Arcturus Therapeutics (ARCT), Monte Rosa Therapeutics (GLUE), Cartesian Therapeutics (RNAC), Candel Therapeutics (CADL), Inhibrx Biosciences (INBX), Prothena (PRTA), Altimmune (ALT), and Tonix Pharmaceuticals (TNXP). These companies are all part of the "pharmaceutical products" industry. Whitehawk Therapeutics vs. Its Competitors Astria Therapeutics Aura Biosciences Arcturus Therapeutics Monte Rosa Therapeutics Cartesian Therapeutics Candel Therapeutics Inhibrx Biosciences Prothena Altimmune Tonix Pharmaceuticals Astria Therapeutics (NASDAQ:ATXS) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Is ATXS or WHWK more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to Astria Therapeutics' net margin of 0.00%. Astria Therapeutics' return on equity of -47.18% beat Whitehawk Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Astria TherapeuticsN/A -47.18% -31.26% Whitehawk Therapeutics 99.42%-56.73%-48.68% Do institutionals and insiders hold more shares of ATXS or WHWK? 99.0% of Astria Therapeutics shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 4.5% of Astria Therapeutics shares are held by insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor ATXS or WHWK? In the previous week, Whitehawk Therapeutics' average media sentiment score of 1.89 beat Astria Therapeutics' score of 0.93 indicating that Whitehawk Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Astria Therapeutics Positive Whitehawk Therapeutics Very Positive Which has more risk and volatility, ATXS or WHWK? Astria Therapeutics has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Do analysts prefer ATXS or WHWK? Astria Therapeutics currently has a consensus target price of $30.00, suggesting a potential upside of 380.77%. Given Astria Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Astria Therapeutics is more favorable than Whitehawk Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Astria Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Whitehawk Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings & valuation, ATXS or WHWK? Whitehawk Therapeutics has higher revenue and earnings than Astria Therapeutics. Astria Therapeutics is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAstria TherapeuticsN/AN/A-$94.26M-$1.87-3.34Whitehawk Therapeutics$25.98M3.35-$63.69M$0.1611.56 SummaryWhitehawk Therapeutics beats Astria Therapeutics on 8 of the 15 factors compared between the two stocks. Get Whitehawk Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WHWK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WHWK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WHWK vs. The Competition Export to ExcelMetricWhitehawk TherapeuticsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$91.86M$761.07M$2.18B$9.35BDividend YieldN/A4.84%2.60%4.06%P/E Ratio11.561.3922.2019.86Price / Sales3.3525.51106.8299.96Price / CashN/A19.5613.4057.94Price / Book0.876.7275.835.67Net Income-$63.69M-$4.32M-$127.36M$257.80M7 Day Performance-6.09%0.00%0.85%1.07%1 Month PerformanceN/A1.41%2.54%11.31%1 Year PerformanceN/A-1.96%22.67%17.01% Whitehawk Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WHWKWhitehawk TherapeuticsN/A$1.85-5.1%N/AN/A$91.86M$25.98M11.5640Positive NewsATXSAstria Therapeutics1.6257 of 5 stars$6.33+0.3%$30.00+373.9%-46.5%$357.23MN/A-3.3930AURAAura Biosciences2.5984 of 5 stars$6.95+5.9%$22.00+216.5%-24.9%$349.38MN/A-3.6650News CoveragePositive NewsARCTArcturus Therapeutics1.9612 of 5 stars$12.85-2.3%$54.00+320.2%-49.4%$348.49M$152.31M-5.08180News CoverageGLUEMonte Rosa Therapeutics2.1963 of 5 stars$5.61+7.3%$15.33+173.3%+15.2%$345.07M$75.62M70.1390News CoveragePositive NewsRNACCartesian Therapeutics2.2634 of 5 stars$13.27-2.3%$40.00+201.4%-26.3%$344.41M$34.17M-0.2564CADLCandel Therapeutics2.4884 of 5 stars$6.85+9.6%$22.00+221.2%-6.0%$343.19M$120K-5.1160Positive NewsAnalyst RevisionINBXInhibrx Biosciences2.5744 of 5 stars$23.65+3.0%N/A+64.1%$342.36M$200K0.20166PRTAProthena3.6134 of 5 stars$6.32+1.6%$31.50+398.4%-73.8%$340.21M$135.16M-3.04130ALTAltimmune2.2242 of 5 stars$4.18flat$18.20+335.4%-48.4%$339.03M$20K-3.3250TNXPTonix Pharmaceuticals2.5355 of 5 stars$45.06+1.9%$585.00+1,198.3%-26.2%$331.64M$10.09M-0.0250Gap Up Related Companies and Tools Related Companies ATXS Competitors AURA Competitors ARCT Competitors GLUE Competitors RNAC Competitors CADL Competitors INBX Competitors PRTA Competitors ALT Competitors TNXP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WHWK) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Whitehawk Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Whitehawk Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
